• 1
    MacGowan GA, Parry G, Schueler S, Hasan A. The decline in heart transplantation in the UK, Editorial. BMJ. 2011;342:d2483.
  • 2
    Deng MC, Ardehali A, Shemin R, et al. Relative roles of heart transplantation and long-term mechanical circulatory support in contemporary management of advanced heart failure – a critical appraisal 10 years after rematch. Eur J Cardiothorac Surg. 2011;40:781782.
  • 3
    Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357(9):885896.
  • 4
    Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with a continuous-flow left ventricular assist device. N Engl J Med. 2009;361(23):22412251.
  • 5
    Larose JA, Tamez D, Ashenuga M, Reyes C. Design concepts and principle of operation of the HeartWare ventricular assist system. ASAIO J. 2010;56(4):285289.
  • 6
    Wieselthaler GM, O’Driscoll G, Jansz P, Khaghani A, Strueber M; HVAD Clinical Investigators. Initial clinical experience with a novel left ventricular assist device with a magnetically levitated rotor in a multi-institutional trial. J Heart Lung Transplant 2010;29(11):12181225.
  • 7
    Strueber M, O’Driscoll G, Jansz P, Khaghani A, Levy WC, Wieselthaler GM; HeartWare Investigators. Multicenter evaluation of an intrapericardial left ventricular assist system. J Am Coll Cardiol 2011;57(12):13751382.
  • 8
    Gordon B, Biss T, Butt T, et al. Platelet mapping thromboelastography for individualized antiplatelet treatment after implantation of the HeartWare ventricular assist device. J Heart Lung Transplant. 2011;30:S208S209. Abstract.
  • 9
    Wasserman K, Beaver WL, Whipps BJ. Gas exchange theory and the lactic acidosis (anaerobic) threshold. Circulation. 1990;81(suppl II):II-14II-30.
  • 10
    MacGowan GA, Cecchetti A, Murali S. Ventilatory drive during exercise in congestive heart failure. J Cardiac Failure. 1997;3:257262.
  • 11
    Lee WH, Packer M. Prognostic importance of serum sodium concentration and its modification by converting enzyme inhibition in patients with severe chronic heart failure. Circulation. 1986;73:257267.
  • 12
    MacGowan GA, Neely D, Peaston R, et al. Evaluation of NT-proBNP to predict outcomes in advanced heart failure. Int J Clin Pract. 2010;64:892899.
  • 13
    Haft J, Armstrong W, Dyke DB, et al. Hemodynamic and exercise performance with pulsatile and continuous-flow left ventricular assist devices. Circulation. 2007;116:I-8I-15.
  • 14
    Kato TS, Chokshi A, Singh P, et al. Effects of continuous-flow vs pulsatile-flow left ventricular assist devices on myocardial unloading and remodeling. Circ Heart Fail. 2011;4:546553.
  • 15
    Page E, Cohen-Solal A, Jondeau G, et al. Comparison of treadmill and bicycle exercise in patients with chronic heart failure. Chest. 1994;106(4):10021006.
  • 16
    Krabatsch T, Schweiger M, Dandel M, et al. Is bridge to recovery more likely with pulsatile left ventricular assist devices than with nonpulsatile-flow systems? Ann Thorac Surg. 2011;91(5):13351340.
  • 17
    Hayward CS, Salamonsen R, Keogh AM, et al. Effect of alteration in pump speed on pump output and left ventricular filling with continuous-flow left ventricular assist device. ASAIO J. 2011;57(6):495500.
  • 18
    Maeder MT, Leet A, Ross A, et al. Changes in right ventricular function during continuous-low left ventricular assist device support. J Heart Lung Transplant. 2009;28:360366.
  • 19
    Butt TA, Oezalp F, O’Leary D, et al. Right ventricular optimisation in patients with biventricular failure receiving a left ventricular assist device – a safe strategy to avoid mechanical RV support. J Heart Lung Transplant. 2011;30:S44S45, Abstract.
  • 20
    Palardy M, Nohria A, Rivero J, et al. Right ventricular dysfunction during intensive pharmacologic unloading persists after mechanical unloading. J Card Fail. 2010;16:218224.